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TPA and a non-promoting, pro-inflammatory ester RX were used to stimulate the forms of PKC isolated from human 
mononuclear cells. Three peaks of kinase activity corresponding to y, B and a PKC were stimulated by TPA in the pres- 
ence and absence of calcium and/or phosphatidylserine (PS) but were not activated by RX. A fourth peak eluted at high 
phosphate concentration was activated by TPA and RX in the presence of PS and the absence of calcium. Activity in 
this fraction was labile to freezing and thawing and was inhibited by staurosporine. 
Protein kinase C; Kinase activity; Ca2+ independence; Phosphatidylserine dependence; Tetradecanoylphorbol acetate; Resiniferatoxin; 
(Human mononuclear cell) 
1. INTRODUCTION 
The tumour-promoting TPA receptor, PKC [ 11, 
exists in a number of isoenzymic forms [2] which 
are variously distributed in tissues [3]. A number 
of tigliane esters (phorbol derivatives) and struc- 
turally related daphnane esters (resiniferonol 
derivatives) are known to both activate and bind to 
PKC(s) as isolated from mammalian brain [4]. Not 
all of these compounds are tumour-promoting 
agents [5] and several derivatives have selective 
biological actions e.g. platelet aggregatory, 
mitogenic and prostaglandin secreting. For the 
trans-ring AB compounds the property of inducing 
inflammation of skin is common to all esters in- 
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vestigated to date including the tumour-promoting 
derivatives [6]. The daphnane derivative RX is 
unusual in this series of compounds in that it is not 
a tumour-promoting agent but is one hundred 
times more potent than TPA in inducing erythema 
of skin [6]. RX was isolated from Euphorbia 
species and its structure obtained by means of par- 
tial synthesis [7]. The daphnane nucleus differs 
from the tigliane nucleus of the phorbols in that 
the dimethylcyclopropane ring D has opened out 
to form an isopropenyl side chain (fig. 1). The two 
groups of diterpenes are thought to be biosyn- 
thetically related and their configurations are iden- 
tical [S]. However RX, at the same dose levels as 
that which induced 100% activation of mixed rat 
brain PKC(s) by TPA, was found to produce a 
maximal stimulation of only 25% [4]. It is possible 
that the selective actions of certain diterpenes 
could be explained on the basis of differential ac- 
tivation of one or more PKC subtypes or due to 
different co-factor requirements. It was of interest 
to compare the abilities of TPA and RX to activate 
the PKC forms isolated from mononuclear cells in 
the presence and absence of PS and calcium. 
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Diterpenes used for the stimulation of kinase activity. RX was isolated from Euphorbia species. TPA was purchased 
Sigma, Poole. 
2. MATERIALS AND METHODS 
2.1. Preparation of mononuclear cells 
Human mononuclear cells were prepared from fresh human 
blood (2 1) by standard techniques of differential density cen- 
trifugation on Ficoll Hypaque (BDH, England). Donors were 
healthy males free from any medication for the previous 10 
days. No more than 500 ml of blood was collected from each 
donor and separately processed prior to hydroxyapatite 
chromatography. Mononuclear cells (4 x 10m8 cells) were cen- 
trifuged at 250 x g for 10 min and the pellet resuspended in buf- 
fer A [20 mM Tris, 0.25 M sucrose, 100 pg.ml-’ leupeptin 
(Sigma, Poole, England), 10 mM EGTA, 2 mM EDTA, 1 mM 
DTT, pH 7.51. Cells were lysed by sonication using three 10 s 
bursts and recentrifuged at 15000 x g. 
2.2. Hydroxyapatite chromatography 
The supernatant was immediately loaded onto a hydrox- 
yapatite column (Biorad HTP Biogel) connected to an FPLC 
machine (Pharmacia, FPLC systems). The column was washed 
for 20 min with buffer B (20 mM potassium phosphate, 1 mM 
EGTA, 10% glycerol, 1 mM DTT, pH 7.5) before a linear gra- 
dient of 20-500 mM potassium phosphate was initiated. Frac- 
tions of 1 ml were collected on ice and stored in 16% glycerol, 
0.02% Triton X-100 at - 80°C for no longer than 6 days before 
assay. 
2.3. Assay for kinase activity 
Assays were performed on all fractions for kinase activity by 
measuring the transfer of 32P from [Y-~~P]ATP to histone 111s 
(Sigma, Poole) [9]. PS (Lipid Products, Nutfield, Surrey) was 
dried under nitrogen and resuspended in Triton X-100 (3%, 
w/v) in buffer C (6.25 mM EGTA, 25 mM Tris-HCl, pH 7.5) 
in the molar ratio of 80% Triton X-100 to 20% PS. Diterpene 
esters were added in the molar ratio of 0.03%. The micelles 
were bath sonicated and vortex-mixed before 50~1 of histone 
111s (5 mg.ml -’ in buffer C) was added to 25 ~1 of micelles 
together with 25 ~1 of enzyme. The reaction commenced with 
the addition of 150 pl of [y-32P]ATP in buffer C to give a final 
concentration of 300 nCi.well-‘, 10 mM magnesium chloride, 
160 
100 PM ATP, 5.1 mM EGTA and calcium chloride if present in 
a final concentration of 5.1 mM (free calcium concentration 
calculated as between 50 and 120 PM). After 10 min at 20°C the 
reaction was terminated with the addition of 1 ml of 25% 
trichloroacetic acid followed by 1 ml of BSA (0.5 mg.ml-‘) as 
carrier. The precipitated protein was separated by filtration 
(Whatman GF/C filters) and washed with 2 x 5 ml of 25% 
trichloroacetic acid. The 32P incorporated into histone was 
measured by liquid scintillation spectrometry. 
2.4. Immunoblotting of column fractions 
PKC monoclonal antibody was obtained from Amersham 
(MCS, data sheet 11800). Essentially the ‘Western’ blotting 
technique was used in these experiments. The proteins, 500 ~1, 
were concentrated by ultracentrifugation using Amicon Cen- 
triflo cones CFSOA and then blotted onto Hybond C- 
nitrocellulose membrane following SDS-PAGE [lo,1 11. MC5 
antibody (RPN 536) diluted 1: 100 with 0.1 Vo BSA in TBS was 
incubated with the membrane for 4 h at room temperature and 
the nitrocellulose membrane washed 4 times for 5 min with 
0.1% (w/v) BSA/O. 1070 Tween 20 in TBS. It was then incubated 
with anti-mouse IgG-peroxidase conjugate (Amersham, NA 
93 1) diluted with 0.1% (w/v) BSA/O. 1 Vo Tween 20 in TBS for 
30 min at room temperature and then washed 4 times for 5 min 
with 0.1% Tween 20 in TBS. Finally, the nitrocellulose mem- 
brane was stained for the peroxidase reaction with 
chloronaphthol solution (0.18 mg.ml-’ in 6% methanol in 
TBS). 0.25 ~1. ml-’ of a 30% hydrogen peroxidase solution was 
added prior to incubation. The molecular masses of the 
immuno-stained protein bands were determined by reference to 
standards (Pharmacia low-molecular-mass protein standard 
mixture) which were separately stained using Janssen Autodye 
Forte colloidal gold reagent [12]. 
3. RESULTS AND DISCUSSION 
Kinase activity stimulated by the diterpene esters 
was compared to the basal activity supported by 
PS alone; calcium was either omitted or included 
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(final concentration 50-120 PM) to investigate the 
calcium-dependence of the various kinase activities 
identified [9]. Using a novel phosphate gradient we 
were able to elute four peaks of kinase activity 
from a hydroxyapatite column. Peak (I) was eluted 
at 160 mM, peak (II) at 200 mM, peak (III) at 
275 mM and peak (IV) at 460 mM phosphate 
(fig.2A). From preliminary experiments using a 
phosphate gradient 20-250 mM two major peaks 
were obtained which from their elution profiles 
corresponded to type I (y) and type II (possibly 
two forms of p) PKC, with a suggestion that type 
III (CZ) PKC might also have been separated. With 
the new gradient a fourth peak of activity was ob- 
tained well removed from the normal forms of 
PKC (fig.2A). TPA in the presence of PS and 
calcium stimulated the kinase activities of peaks (I) 
to (III) and this stimulated activity was less in the 
absence of calcium (fig.2A). From fig.2A it is evi- 
dent that the use of a potent probe, TPA, in the 
presence of PS makes possible the demonstration 
of a peak of kinase activity from human 
mononuclear cells which possibly corresponds to 
the y form of PKC. Four types of PKC have been 
identified from human cells [ 131. It remains to be 
seen whether this peak corresponds to type I PKC 
as demonstrated from rat brain [ 141. The kinase 
activity, stimulated by TPA in the presence of PS 
but only in the absence of calcium, which was 
eluted from hydroxyapatite at high phosphate con- 
centration has not previously been demonstrated in 
cell or tissue PKC profiles. This peak was not evi- 
dent in the profile obtained by the use of PS, or 
TPA and calcium (table 1). 
The daphnane ester, RX, has previously been 
shown to stimulate mixed preparations of mam- 
malian brain PKC [4]. However, we demonstrate 
here (fig.2B) that in the presence of PS and in the 
presence of PS with calcium, RX failed to activate 
kinase activities (I) to (III) that are stimulated by 
TPA and correspond to the major subtypes of 
PKC currently described. Such a result may be 
consistent with the fact that RX is a non- 
promoting diterpene in Berenblum-type tumour- 
promoting experiments [15]. However, RX in the 
presence of PS did induce kinase activity of the 
peak (IV) which eluted with a high phosphate con- 
centration from the column. This activity, which 
was not seen in the presence of calcium, cor- 
responded to the activity stimulated by TPA with 
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Fig.2. Kinase activity isolated from human mononuclear cells 
obtained by elution from hydroxyapatite chromatography with 
a phosphate gradient of 20-500 mM as measured by 
[y-3ZP]ATP incorporation into histone 111s [9]. Fractions were 
collected at intervals of 1 ml. Peaks labelled I to IV represent 
the peaks of kinase activity different to PS between (A) TPA, 
molar ratio 0.03%, plus PS (0) and TPA as before with PS 
and calcium (0); and (B) RX, 0.03% molar ratio, plus PS (0) 
and RX as before plus PS and calcium (0). 
PS from the same lymphocyte kinase fractions. 
When tested at the same concentration, stimula- 
tion of kinase activity (IV) by RX was greater than 
that seen with TPA. It is clear that stimulation of 
kinase activity (IV) evoked by either TPA or RX 
was seen only when calcium was absent (table 1). 
This kinase may be inhibited by calcium or a 
calcium-activated phosphatase may be present. 
The enzymatic nature of this kinase activity, term- 
ed RX-kinase, was demonstrated by assaying this 
fraction in the presence of the kinase inhibitor 
staurosporine, at a final concentration of 1 pM, 
whereupon the activation induced by either RX or 
161 
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Table 1 
Stimulation by diterpene esters at the denoted peaks in fig.ZA 
and B in multiples of the control (PS or PS plus calcium) levels 
Peak Cofactors Stimulant Ratio of stimu- 
lated to control 
activities 
I PS - Ca*+ TPA 3.0 (0.70) 
PS + Ca*+ TPA 4.0 (0.52) 
II PS - Ca’+ TPA 1.7 (0.12) 
PS + Ca*+ TPA 2.8 (0.27) 
III PS - Ca*+ TPA 1.6 (0.13) 
PS + Ca*+ TPA 1.9 (0.12) 
IV PS - Ca*+ TPA 2.2 (0.84) 
PS - Ca*+ RX 5.2 (1.13) 
PS + Ca*+ TPA 1.3 (0.22) 
PS + Ca” RX 1.7 (0.33) 
Each value gives the stimulation induced by the diterpene above 
the control and represents the mean t SE of five separate 
experiments. Assays as described in the legend to fig.2 were also 
carried out on the peaks I to IV by incorporating staurosporine 
(Fluka AG, Buchs, Switzerland) into the micelles together with 
the diterpene esters to give a final concentration of 1 pM 
staurosporine 
TPA plus PS was inhibited. Activity in these frac- 
tions was also lost when the fractions were re- 
assayed after freezing and thawing the samples at 
-20°C over a period of days. RX-kinase activity 
was not supported by PS alone but required the 
presence of PS for full stimulation by RX to be 
observed. These observations suggest that the 
‘receptor’ for the daphnane group of diterpenes is 
a novel kinase, distinct from the known subtypes 
of PKC, that require PS but not calcium for ac- 
tivity. 
In order to characterise this kinase further we 
have investigated the cross-reactivity of a 
monoclonal antibody to PKC. The antibody cross- 
reacts with the LY andp forms of PKC Ca, recognis- 
ing an epitope residue 312-323 of PKC, which is 
absent from the y form of PKC. A representative 
blot (fig.3) shows that the proteins of 77-79 kDa 
present in fractions 13-17 cross-reacted with the 
antibody, suggesting that the ,L? and LY forms of 
PKC corresponded to peaks II and III, respective- 
ly, in fig.2A. Samples from fraction 11 (our peak 
I) did not cross-react with the antibody, consistent 
with this being the y form of PKC and in contrast 
to the results of Shearman and others [16] using a 
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Fig.3. Immunoblotting of the fractions from fig.ZA and B as 
isolated from hydroxyapatite chromatography of the 
supernatant from human mononuclear cells. Fraction numbers 
are indicated in that figure and proteins of standard molecular 
mass were run in parallel. 
diacylglycerol as stimulating agent. Fractions 
33-35 (our peak IV) which contained the RX- 
kinase did not cross-react with the PKC antibody. 
This supports the view that RX-kinase is distinct 
from the a and ,4 forms of PKC. 
We have several ines of evidence which lead to 
the preliminary conclusion that RX-kinase is 
distinct from the major sub-types of PKC: these 
include (i) elution from hydroxyapatite by high 
concentrations of phosphate; (ii) calcium- 
independence of the PS-dependent kinase activity; 
(iii) failure to cross-react with antibody MCS. 
Other calcium-independent, phospholipid-depen- 
dent kinases have been described. For example, 
Ohno and others 1171 described the expression of 
an encoded protein which is a phorbol ester recep- 
tor and was regulated by phospholipid in a 
calcium-independent manner. This kinase, known 
as nPKC was also regulated by diacylglycerol 
(DAG) but was entirely different from forms of 
PKC which were calcium regulated. Although 
TPA and DAG both utilise PKC to mediate cell 
signal transduction they may induce different ef- 
fects biologically. Certainly different structural 
types of the phorbol and the daphnane esters have 
a number of non-correlatable ffects in vivo and in 
vitro [6], for example, TPA is fully mitogenic in 
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human lymphocyte cultures, whilst the non- 
mitogenic RX is co-mitogenic in the mixed lym- 
phocyte reaction (results not shown). These effects 
could involve a family of kinases such as nPKC or 
PAKII (protease-activated kinase II) [18] which 
are independent of calcium but not PS. The role of 
calcium, as yet unknown co-factors and substrates 
other than histone 111s may become apparent when 
investigated by means of selective, highly active, 
diterpene probes such as RX. As an initial step we 
have shown that this highly potent inflammatory 
substance capable of inducing pain and erythema 
does not activate the calcium-dependent forms of 
PKC but instead activates a distinct RX-kinase ac- 
tivity present in human mononuclear cells. 
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